Rekah Pharmaceutical Prod (XTAE:REKA) Short Percentage of Float


XTAE:REKA Rekah Pharmaceutical Prod Ltd XTAE:REKA
57 GF Score
Price ₪10.97
GF Value ₪13.05
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Rekah Pharmaceutical Prod Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XTAE:REKA vs ZTS, UTHR, VTRS: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rekah Pharmaceutical Prod's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rekah Pharmaceutical Prod Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rekah Pharmaceutical Prod's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Rekah Pharmaceutical Prod's Short Percentage of Float falls into.


XTAE:REKA
57GF Score
Rekah Pharmaceutical Prod Ltd XTAE:REKA
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Rekah Pharmaceutical Prod (XTAE:REKA) Overvalued in 2026?

Based on GuruFocus' analysis, Rekah Pharmaceutical Prod stock appears to be undervalued. The current stock price of ₪10.97 is trading 15.9% below its estimated GF Value™ of ₪13.05. GuruFocus considers Rekah Pharmaceutical Prod to be Modestly Undervalued.

Key valuation signals for XTAE:REKA:

  • Short Percentage of Float:
  • GF Value™: ₪13.05 vs. price of ₪10.97 (15.9% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the XTAE:REKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rekah Pharmaceutical Prod Business Description

Address 30 Hamelacha Street, Holon, ISR
Rekah Pharmaceutical Prod Ltd is engaged in the manufacturing, importing, marketing, and distribution of pharmaceuticals and cosmetics. It primarily caters to the needs of hospitals, retirement homes, and national medical healthcare services.
57GF Score

Get the complete analysis for XTAE:REKA

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪10.97
Price
₪13.05
GF Value